You are here: Industry Insights > Brand Story > SPI Pharma - Exhibitor Webinar

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Avatrombopag Maleate

BioHub® Magnetic Separator

Avatrombopag

Ursodeoxycholic acid

Troxerutin

CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

SPI Pharma - Exhibitor Webinar

August 07, 2020

Tag: Exhibitor Webinar , VEC , CPHI China

Favorites

Company Name: SPI Pharma

Title：Innovation in Mannitol - SPI Pharma's New XL Technology to Enhance Performance in DC Formulation

Speaker: Wayne Camarco ?

Position：Global Head of Technical Development

Wayne joined SPI Pharma in 2019 as Global Head of Technical Development. Wayne brings broad-based excipient and API experience in the areas of formulation development and technical service. He has worked in a variety of technical, sales and business development roles at ACG Capsules, Juniper Pharma (Catalent UK), Ashland Specialty Ingredients in US and Rhodia in US & France.

For more information, click here to view my store.

Previous:Canada signs deals with Pfizer, Moderna for supply of COVID-19 vaccines

Next:AstraZeneca signs first deal to supply Covid-19 vaccine in China

What companies are developing CNS drugs in China?

ChatGTP/PharmaSourcesNovember 08, 2023

Several pharmaceutical and biotechnology companies in China are actively involved in the research and development of Central Nervous System (CNS) drugs.

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

PharmaSourcesMay 15, 2023

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

PharmaSources.comMay 27, 2022

SPI Pharma - Exhibitor Webinar | Pharmasources.com

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

PharmaSources.comDecember 30, 2021

Ningxia Taiyicin founded in 2010, covering about 221.73 hectares of construction area with registered capital RMB 625 million, is mainly established for Non-sterile API and pharmaceutical intermediates.

SPI Pharma - Exhibitor Webinar

Related News

What companies are developing CNS drugs in China?

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

You may like
More>>

SPI Pharma - Exhibitor Webinar

Related News

What companies are developing CNS drugs in China?

Shanghai Dayou Chromatagraphy Technology Service Co., Ltd.——Professional chromatographic filler supplier for industrial scale production

International Perspective, Cutting-edge Technology Learning - Entering into HongKe(虹科) Technology Co., Ltd.

Established For Non-Sterile API and Pharmaceutical Intermediates, Ningxia Taiyicin Biotech Co., LTD.

You may likeMore>>

You may like
More>>